GlobeNewswire Clinical StudiesOriginal article
NeOnc Reports Second Quarter 2026 Financial Results and Confirms August 12 Topline Phase 2a NEO100 Data Readout
Data ReadoutNEO100Neutral
AI Analysis
Summary
NeOnc announced Q2 2026 financial results and confirmed the topline Phase 2a data readout for NEO100 is scheduled for August 12, 2026. The announcement provides timing for an upcoming clinical trial data disclosure.
Clinical Trial Data
Phase
2a
Importance:7/10
Sentiment:
0.00
Phase_2aData_ReadoutNEO100Financial_Results
Related Companies
Read the original article
Published by GlobeNewswire Clinical Studies on August 10, 2026 1:00 PM